BID Equity provides access to the hidden champions of the European software industry.

The investors of the BID Equity Funds are leading institutional  asset managers: From pension funds to family offices and endowments

The BID Equity Group provide access to Software "Mittelstand"

Europe is a stronghold of "hidden software champions" and BID Equity allows institutional investors to get exposure to this sector.

Fast growing software firms are often associated with the Silicon Valley. But Europe and the DACH-region in particular have a very healthy sector of specialised software firms that often have a regional rather than a global positioning. These firms differentiate themselves through intimate customer knowledge and have a high exposure to the trends of digitalization.


BID Equity has developed a very structured approach to identify such hidden champions and to help them operationally to continue their growth while professionalizing their organisation.

WHAT’S HAPPENING IN the BID Portfolio

17 Jul 2024

After a successful history of joint cooperation, FarMedvisie and MediCheck App are pleased to inform about FarMedvisie’s acquisition of MediCheck App. The combination of MediCheck App’s mobile SaaS solution for medication intake administration with FarMedvisie’s ePrescription SaaS suite marks an important milestone as from now on, the complete medication lifecycle will be covered by one common platform. Together, the solutions will ensure medication safety for more than 200,000 patients per year.

28 May 2024

BID Equity Fund III announces the acquisition of REALVIEW AG, a renowned Swiss provider of modern software solutions in the field of construction project management.

03 Oct 2023

JustRelate Group, a leading provider of a powerful and holistic "digital experience platform" (DXP), has acquired French Bmobile with its innovative email builder Dartagnan.

21 Sep 2023

EvidentIQ, an international provider of clinical trial software, has completed the acquisition of a majority stake in asthenis GmbH, the market leader in cancer documentation software in Germany and Switzerland. Marcus van den Bergh, founder of asthenis, will continue to support the company and its customers in his role as managing director and shareholder.